Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

10:18 EDT 5th September 2015 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 6,900+

Wednesday 2nd September 2015

ex scientia Ltd. reaches first delivery milestone in collaboration with Sumitomo Dainippon Pharma Co., Ltd.

ex scientia Ltd. is pleased to announce the achievement of delivering its first advanced molecule that fits the development quality criteria requested by Sumitomo Dainippon Pharma Co., Ltd. after the first year of their collaboration. ex scientia and Sumitomo Dainippon researchers are working in partnership to deliver novel multi-target small mole...

Dicerna Pharmaceuticals Submits Investigational New Drug (IND) Application for DCR-PH1, an Investigational Therapy for Primary Hyperoxaluria Type 1 (PH1)

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leading developer of RNA interference (RNAi) therapeutics, today announced the submission of an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for DCR-PH1, the company's therapeutic candidate for the treatment of primary hyperoxaluria type 1 (PH1). PH1 is a severe, ra...

Acceleron Pharma to Present at Upcoming Investor Conferences in September

Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced it will participate in the following upcoming investor conferences.   ...

Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences

Presentations to be Webcast on September 10 at 3:10 p.m. ET and September 16 at 9:20 a.m. ET Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Execu...

How protein tangles accumulate in the brain and cause neurological disorders

A new Sanford Burnham Prebys Medical Discovery Institute (SBP) study takes a step forward in understanding how similar, yet genetically unrelated neurodegenerative diseases, such as Alzheimer's disease, frontal temporal dementia, and progressive supr...

Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency

CHARLOTTESVILLE, Virginia, September 2, 2015 /PRNewswire/ -- Biovista Inc. is glad to announce the sponsoring of the winners of the 2015 BeHEARD science challenge, a global competition hosted by the Rare Genomics Institute that offers rare disease researchers, access to the latest life science innovations and technologies. Biovista will use its drug repositioning and pathway analytics capability...

Kerafast Partners with the National Cancer Institute (NCI) - Enables Sharing of NCI Research Materials through Kerafast Platform

Partnership seeks to advance scientific discovery by offering important bioreagents Kerafast Inc., developers of an online platform to facilitate accessibility to unique bioresearch materials from academic and government laboratories across the globe, today announced an agreement to make important research materials from the National Cancer Institute available through Kerafast’s platform. W...

DefiniGEN Licences Lung Stem Cell Technology from University of Cambridge

DefiniGEN Ltd, a leading provider of stem cell life science products and services, today announced that it has strengthened its IP portfolio with a licence for cutting edge lung stem cell technology from the University of Cambridge. The technology will be used by DefiniGEN to develop new, optimised cell products and services for drug discovery and the study of lung diseases, including cystic fibr...

Registration Now Open for Oxford Global’s 2nd Annual Stem Cell Congress 2015

Oxford Global Conferences are delighted to announce the 2nd Annual Stem Cell Congress with our co-located Cell & Gene Therapy is taking place on the 9th & 10th of November in London, UK. Over 170 senior delegates will represent global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions. The Congress will provide over 20 presentations, ...

ADC Therapeutics Secures $80m Financing to Progress its Pipeline of Antibody Drug Conjugate Therapeutics in Oncology.

Lausanne, Switzerland and London, UK and Murray Hill, New Jersey, US, 2 September 2015 – ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, today announced that it has raised $80 million through a private placement of equity. New investors include leading Eur...

Precision BioSciences Announces Appointment of Gene Liau, Ph.D. and Bruce McCreedy, Ph.D. to Management Team

Industry Veterans to Lead ARCUS Gene and Cell Therapy Product Development Precision BioSciences, the genome editing company, today announced two key additions to the executive team - Gene Liau, Ph.D., as Senior Vice President, Gene Therapy and Bruce McCreedy, Ph.D., as Senior Vice President, Cell Therapy. “We are excited to welcome Ge...

ADC Therapeutics Secures $80m Financing to Progress its Pipeline of Antibody Drug Conjugate Therapeutics in Oncology

Lausanne, Switzerland and London, UK and Murray Hill, New Jersey, US, 2 September 2015 – ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, today announced that it has raised $80 million through a private placement of equity. New investors include leading Eur...

Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease

AMRI to Present at Morgan Stanley Global Healthcare Conference 2015

ALBANY, N.Y., Sept. 2, 2015 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference 2015 on Wednesday, September 16, 2015 at 3:40 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web site ...

TapImmune Inc. to Present at 17th Annual Rodman & Renshaw Healthcare Conference

JACKSONVILLE, Fla., Sep. 2, 2015 /PRNewswire/ -- TapImmune, Inc. ( OTCQB: TPIV), a clinical-stage immunotherapy company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, will be featured as a presenting company at the 17th Annual Rodman & Renshaw Global Investment Conference. Sponsored...

Veracyte to Present at Morgan Stanley Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 2, 2015 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2015 at 10:30 a.m. ET in New York, NY. The live audio webcast and subsequent replay may be accessed by visiting Veracyte's webs...

RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials

RetroSense Therapeutics LLC, a privately-held biopharmaceutical company, recently announced the Company’s Investigational New Drug (IND) application for RST-001 received clearance from the United States Food and Drug Administration (FDA)

Gene editing firm receives $70M funding boost

A Series B funding round has pulled in $70 million for Intellia Therapeutics.  -More- 

Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer

Sangamo and Shire Restructure Collaboration to Accelerate Development of ZFP Therapeutics® for the Treatment of Hemophilia and Huntington's Disease

RICHMOND, Calif., Sept. 2, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO), a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc (LSE: SHP, NASDAQ: SHPG), have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease. Th...

New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG

Developed through industry partnerships, the leading platform for all in-vitro screening again raises the bar on efficiency, versatility, and consistency. Telford, England (PRWEB) September 02, 2015 Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today unveiled Genedata Screener® version 13.0 at ELRIG Drug Discovery 2015. This latest ...

OncoSec to Present at Scientific and Investment Conferences in September

SAN DIEGO, Sept. 2, 2015 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members of its leadership team will be making presentations at several high-profile events in September, including: First World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine a...

Tuesday 1st September 2015

NanoCellect and UCSD Team Up on Single-Cell Sorting and Analysis

San Diego, CA, September 02, 2015 --(PR.com)-- NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life science researchers, begins a collaboration with UCSD to develop single cell applications based on their WOLF Cell Sorter. The WOLF Cell Sorter enables easy-to-use cell sorting that avoids the biohazards and shear stress of traditional...

Insight Genetics Launches Insight RET Screen(TM), a Novel Solution for Biomarker-Driven Lung Cancer

NASHVILLE, TN -- (Marketwired) -- 09/02/15 -- Insight Genetics, Inc. today announced the launch of its Insight RET Screen™, a Clinical Laboratory Improvement Amendments (CLIA)-validated assay available through Insight Molecular Labs, that detects oncogenic RET (Rearranged during Transfection) expression in non-small cell lung cancer (NSCLC) patients. The Insight RET Screen is a qPCR assay that d...

Global Gene Therapy Market Study 2015 - Technologies, Markets and Companies Analysis 2014-2024

Dublin, Sept. 02, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/f3dmcs/gene_therapy) has announced the addition of Jain PharmaBiotech's new report "Gene Therapy - Technologies, Markets and Companies" to their offering. The markets



Advertisement
 
Advertisement
 

News Quicklinks